← Back to federal legislation
H.R. 1060In committee

Modern Authentication of Pharmaceuticals Act of 2025

Introduced: Feb 6, 2025

Latest action date: Feb 6, 2025

Latest development

Referred to the House Committee on Energy and Commerce.

Civixly approval

No ratings yet

0 ratings

Not enough ratings yet. Public approval appears at 5+ ratings.

Your view
0 comments
Congress
119th Congress
Introduced
Feb 6, 2025
Recorded roll calls
0

Status detail: The most advanced recorded stage is committee consideration.

Plain-language overview

What this bill does

Modern Authentication of Pharmaceuticals Act of 2025

This bill requires each dose of a pharmaceutical product that is a controlled substance and that is taken orally in solid form (i.e., pills) to include a physical chemical identifier. (Physical chemical identifiers are substances that possess a unique physical or chemical property, such as inks, pigments, flavors, and molecular taggants, that unequivocally identify and authenticate a drug or dosage.) Under the bill, physical chemical identifiers must be included in or on the product and must be machine readable.  

The bill applies to products manufactured beginning five years after the bill's enactment.

Official summary from Congress.gov.

Civixly topics

What this legislation is about

Civixly topics make federal and state legislation comparable. They are derived from the official CRS policy area and legislative subjects.

Official CRS policy area

Health

View 4 official legislative subjects
Drug safety, medical device, and laboratory regulationDrug trafficking and controlled substancesPrescription drugsSupply chain

Committee activity

Committees and subcommittees that received, reviewed, marked up, or reported this legislation.

Amendments

Proposed changes to this measure, with their latest official outcome or action from Congress.gov.

No amendments are listed for this measure.

Checked against Congress.gov Oct 22, 2026.

Action timeline

Newest action first. Action language comes from the official Congress.gov record.

View full action timeline4 actions
  1. Referred to the House Committee on Energy and Commerce.

    IntroReferralHouse floor actions
  2. Sponsor introductory remarks on measure. (CR H519)

    IntroReferralLibrary of Congress
  3. Introduced in House

    IntroReferralLibrary of Congress
  4. Introduced in House

    IntroReferralLibrary of Congress

Roll-call votes

Recorded House and Senate votes connected to this bill. Your representatives appear first when available.

No connected roll-call votes are currently available for this bill.

Discussion

0 comments across 0 threads

Sign in to join the discussion.Comments are publicly visible.

Loading comments...

Sources: Congress.gov and official House and Senate vote records.

View data freshness details

Base metadata check pending · Civixly summary check pending · Action timeline checked Oct 22, 2026 · Complete sponsorship check pending · Topics checked Oct 22, 2026 · Committees checked Oct 22, 2026 · Status checked Oct 22, 2026 · Related bills checked Oct 22, 2026.